All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
Some previous tissue mapping systems acquire the position of multiple points on the surface of the tissue to be mapped, and use the individual point positions to generate an image of the target tissue surface by interpolating a surface between the individual points. To acquire the position of each point, a user positions a probe at the point on the surface, and the position of the point is recorded. The user moves the probe to multiple points on the surface, and the position is recorded for each point. To create a 3D model of the surface using this and similar methods, the mapping probe must be moved to a relatively large number of points on the surface to be mapped, which increases the procedure time. Additionally, models generated using these techniques include measured position information only for the points that are actually touched by the probe during the mapping procedure; the rest of the surface points are interpolated and thus subject to error.
It would be beneficial to be able to map tissue without having to use methods that require a point-by-point position sensing in order to create a model of the target tissue.
The disclosure relates generally to devices and systems adapted for, and methods of, creating a patient map.
One aspect of the disclosure is a method of using of a cardiac visualization catheter to create a patient map, comprising: positioning an ablation catheter within a patient adjacent tissue to be mapped, the ablation catheter comprising an expandable member that includes an expandable membrane, at least one camera disposed within the expandable membrane, the camera having a field of view, the camera orientated such that the camera field of view includes a portion of the expandable membrane when the expandable membrane is expanded, and a locational element with a fixed position and orientation relative to the camera, wherein the position and orientation of the location element are defined in a global frame of reference and detectable by a locational element detector; delivering a fluid into the expandable membrane to at least partially inflate the expandable membrane; contacting the patient with at least a portion of the expandable membrane; capturing, with the camera, a plurality of different 2D images of the patient's anatomy adjacent the expandable member, each of which visualizes at least one part of the patient that is in contact with the expandable membrane; tagging each of the plurality of different 2D images with information indicative of the position and orientation of the locational element when each of the plurality of different 2D images was captured; creating a patient map, wherein creating the patient map comprises placing each of the plurality of different 2D images at the corresponding tagged position and orientation into a 3 space, and displaying the patient map.
In some embodiments the ablation catheter includes a plurality of cameras disposed within the expandable membrane, each of the plurality of cameras having a different field of view, the locational element having a fixed position and orientation relative to each of the cameras, and wherein capturing a plurality of different 2D images with the camera comprises capturing a plurality of different 2D images with the plurality of cameras, each of the different 2D images including the fields of view of the plurality of cameras, and wherein the tagging step comprises tagging each of the plurality of different 2D images with information indicative of the position and orientation of the locational element when each of the plurality of 2D images was captured.
In some embodiments creating the patient map comprises projecting the plurality of different 2D images onto a 2D plane, and wherein displaying the patient map comprises displaying the 2D plane.
In some embodiments creating the patient map comprises a 2D patient map projected on a surface defined in a 3D volume where the surface is non planar.
In some embodiments the method further comprises mapping at least one natural landmark into the patient map. Mapping at least one natural landmark into the patient map can comprise mapping at least one pulmonary vein ostium into the patient map.
In some embodiments the method further comprises mapping at least one electrical landmark into the patient map. Mapping at least one electrical landmark into the patient map can comprise mapping at least one electrical landmark selected from the group consisting of: an electrophysiological landmark, a rotor, a nerve cell cluster, a nerve disposed on an inner wall of heart, and a nerve extending adjacent the heart, a conduction bundle within the heart. In some embodiments the electrical landmark is a nerve, the method further comprising delivery energy into tissue and monitoring for a response indicative that the delivery energy into tissue modulated activity in the nerve. In some embodiments the electrical landmark is a conduction bundle, the method further comprising delivery energy into tissue and monitoring for a response indicative that the delivery energy into tissue modulated activity in the conduction bundle. In some embodiments mapping at least one electrical landmark into the patient map comprises sensing electrical activity of tissue in the heart, and mapping the location of aberrant electrical activity.
In some embodiments the method further comprises mapping at least one created landmark into the patient map. Mapping at least one created landmark into the patient map can comprise mapping a zone indicative of where the expandable membrane has made contact with tissue, or has not made contact with tissue. The method can further comprise distinguishing a color in the plurality of images that indicates that contact with tissue has been made from a color in the plurality of image that indicates that contact with tissue has not been made. Mapping at least one created landmark into the tissue map can comprise mapping into the patient map a region of tissue into which ablation energy has been delivered. The method can further comprise injecting a dye into the tissue, and mapping the location of the dye into the patient map.
In some embodiments the camera has a reference frame, the camera reference frame in a fixed position and orientation relative to the location element, and wherein tagging each of the plurality of different images with information indicative of the position and orientation of the locational element when each of the plurality of images was captured comprises determining a position vector in the camera field of view in the global frame of reference. Determining the position vector can comprise using a known distance between the camera and a first scaling element carried by the expandable membrane. The first distance element can be a hub at a distal region of the device, the hub secured directly or indirectly to the expandable membrane. In some embodiments determining the position vector comprises estimating by calculating a distance between the camera and a point on the tissue. Estimating by calculating a distance between the camera and a point on the tissue can use a change in a known image dimension of a marker carried by the expandable member within the image.
In some embodiments the method further comprises delivering a fluid into the expandable membrane and creating a fluid pressure within the membrane that is greater than a threshold, the created fluid pressure creating a substantially constant distance between the camera and the expandable member when the expandable member is pressed against atrial tissue. Pressing the expandable member against atrial tissue can cause the atrial tissue to deform around the expandable member due to the created fluid pressure.
One aspect of the disclosure is an ablation catheter comprising: an expandable membrane, at least one camera disposed within the expandable membrane, the camera having a field of view, the camera orientated such that the camera field of view includes the expandable membrane when the expandable membrane is expanded, and a locational element with a fixed position and orientation relative to the camera, wherein the locational element is adapted such that the position and orientation of the location element can be defined in a global frame of reference and detectable by a locational element detector.
One aspect of the disclosure is a method of combining images from a cardiac ablation visualization system, comprising: providing a plurality of images captured with a visualization element disposed within an expandable member, combining the plurality of captured images using at least one common landmark between the plurality of captured images, wherein the at least one common landmark is selected from the group consisting of an anatomical landmark, an electrophysiological landmark, and a created landmark.
One aspect of the disclosure includes methods of stitching a plurality of images together using one or more landmarks, which can be any of the types of landmarks described herein. Stitching the images together can be done with or without the use of a locational element.
In
The cardiac ablation catheter is configured to deliver ablative energy to tissue such as cardiac tissue and to ablate the tissue. Expandable member 10 includes membrane, or balloon, 12 and a plurality of energy delivery elements 14 secured to the exterior of membrane 12. In this embodiment energy delivery elements 14 are electrodes configured and positioned to deliver ablative RF energy to tissue when expandable member 10 is inflated and to ablate the tissue, and are in electrical communication with an RF generator (not shown) configured to generate RF energy.
Visualization system 30 includes a camera assembly 32 and illumination sources 35 disposed on the guide wire shaft 54. The cameras are configured to enable real-time imaging of the procedure from within the expandable member 10 to visualize the membrane and electrodes, cardiac tissue when the membrane/electrodes and cardiac tissue interface, as well as lesion formation during the ablation procedure, as is described in more detail below.
The materials of the membranes 12 described herein can vary. Generally, the membrane material is thin, readily foldable into a low profile and refoldable after expansion. The materials can be elastic, inelastic, stretchy, non-stretchy, compliant, semi-compliant, or non-compliant. In an embodiment, membrane 12 has an expandable structure and can be constructed of materials such as those materials used in the construction of balloon catheters known in the art, including, but not limited to polyvinyl chloride (PVC), polyethylene (PE), cross-linked polyethylene, polyolefins, polyolefin copolymer (POC), polyethylene terephthalate (PET), nylon, polymer blends, polyester, polyimide, polyamides, polyurethane, silicone, polydimethylsiloxane (PDMS) and the like. Membrane 12 can be constructed of relatively inelastic polymers such as PE, POC, PET, polyimide or a nylon material. Membrane 12 can be constructed of relatively compliant, elastomeric materials including, but not limited to, a silicone, latex, urethanes, or Mylar elastomers. Membrane 12 can be embedded with other materials such as for example, metal, Kevlar or nylon fibers. Membrane 12 can be constructed of a thin, non-extensible polymer film such as polyester or other flexible thermoplastic or thermosetting polymer film. In one embodiment flexible membrane 12 can be about 0.001″ to about 0.002″ in thickness to provide sufficient burst strength and allow for foldability. In some embodiments it is preferable to have the electrode mechanical properties as close to the membrane mechanical properties as possible. One way of providing this is to use an inelastic membrane that will not stretch as it is expanded. This helps secure the branches to the membrane. Membrane 12 has a front, or distal, face that is generally flat but can have other shapes as well.
Expandable member 10 includes what is generally referred to in U.S. Pat. No. 8,295,902, issued Oct. 23, 2012, and U.S. Pub. No. 2012/0071870, published Mar. 22, 2012, as flex circuits. A flex circuit as used herein generally refers to a conductive layer, an insulation layer, and optionally a substrate layer. A flex circuit is in electrical communication with at least one electrode.
The conductor or conductive layer 15 can be a material such as, but not limited to, a metal or metal foil of copper, gold, silver, tin, nickel, steel, cupronickel (copper-nickel alloy), KOVAR (nickel-cobalt ferrous alloy) or other material. In an embodiment, more than one conductive material can be used in the conductive layer 15. In an embodiment, a conductive layer 15 of copper can be plated with a thin layer of an additional conductive material at the conductive pad beneath electrode 14. In an embodiment, the thin layer of additional conductive material can be gold. The flex circuit and its components can be manufactured using techniques as known in the art.
The materials used to create the electrodes 14 can vary. The electrodes 14 can be a thin film of an electro-conductive or optical ink. The ink can be polymer-based for better adhesion to the membrane. The electrode material can be a biocompatible, low resistance metal such as silver, silver flake, gold, and platinum which are additionally radiopaque. Inks may additionally comprise materials such as carbon and/or graphite in combination with the more conductive materials already described. The addition of carbon and/or graphite can increase the conductivity of the polymer matrix. When incorporated as fibers the carbon and/or graphite add additional structural integrity to the ink electrode. Other fiber materials may be substituted to attain the same end. When the electrode material is not particularly radiopaque, additives such as tantalum and tungsten may be blended with the electrode material to enhance radiopacity. An example of an electro-conductive ink is provided by Engineered Conductive Materials, LLC (ECM) which is a polyurethane-based silver loaded ink. Another example is Creative Materials Inc., which manufactures conductive inks, films, as well as radiopaque inks. As mentioned above, the electrodes 14 can be applied to the membrane 12 and flex circuit using an adhesive. Alternatively, the electrode material can have adhesive properties or be an adhesive-loaded with conductive particles such as silver flakes such that electrodes 14 can adhere the components of the flex circuit to the membrane 12. If an additional adhesive layer is used to adhere the electrode 14 to the membrane 12 and flex circuit, the adhesive layer can include a conductive or non-conductive material. The electrodes formed with electro-conductive or optical ink or thin metal film can be visualized under fluoroscopy to provide a general sense of the shape of the membrane and location of the electrode. To enhance visualization under fluoroscopy, radiopaque additives can be included in the electrode material or radiopaque markers laid out next to, on top or below the electrodes as will be discussed in more detail below. Additionally, the bonding layer or substrate will be optimally comprised of a minimally reflective material.
Each of the electrodes is individually addressable, or can be used with any other electrode. The electrodes can operate in monopolar mode or bipolar mode, as is indicated in the exemplary schematic shown in
To prevent or reduce the likelihood of charring of tissue that is in contact with the energy delivery elements and coagulation of blood adjacent the electrodes, each of the flex circuits at the locations of the electrodes includes an irrigation aperture therethrough, and as shown are in the center of the electrodes. The irrigation apertures also prevent the inflation/irrigation fluid inside the membrane from becoming too hot, which would interfere with the ablation. Irrigation fluid, which is also the fluid that inflates membrane 12 causing it to be reconfigured toward its expanded configuration, is pumped from a fluid source through irrigation lumen 52, into membrane 12, through the irrigation apertures (not labeled), and towards the tissue that is in contact with the electrodes to cool the target tissue. One of the drawbacks of previous attempts at cardiac ablation is that the ablation procedures cause blood to coagulate or tissue to char due to lack of a cooling feature. Additionally, since each electrode is individually addressable, and the visualization system allows the operator to identify whether an individual electrode is in contact with tissue, only electrodes in contact with tissue may be turned on. Thus energy is more efficiently coupled to just the sites where ablation is desired and little to no energy is dissipated into the blood.
One of the significant advantages of ablation catheters herein is that, when in use, the ablation procedures can be visualized with an imaging, or visualization, member with a perspective from within the inflatable membrane. In the embodiment in
Illumination sources 35 are configured and positioned to provide illumination generally radially outward towards reflector 22. Diffuse reflector 22 thus diffusely reflects light forward toward the camera's fields of view. The illumination sources thus provide lighting for the cameras to visualize the procedure, including the tissue, and the lesion formation.
In some embodiments the diffuse reflector is printed on the exterior of the balloon. The diffuse reflector can be comprised of silicone or urethane resins filled with nonconductive white pigment such as TiO, BaO, BaSo4, styrene or other polymer beads, or of metal particles. Optimal materials will be minimally reflective such as a black adhesive.
In this embodiment the diffuse reflector is secured to the membrane such that it does not completely overlap any of the electrodes, and is positioned so that the illumination sources, when activated, emit light towards the reflector. In this embodiment the diffuse reflector, or reflectors, is secured to the membrane at a location that does not extend all the way to the distal end of the membrane. In this embodiment the reflector is secured to the membrane such that it does not extend further distally than the proximal-most electrode. In alternative embodiments, however, the reflector can extend distally to the proximal-most electrode in some locations around the membrane. For example, the distal edge of the reflector can be curved rather than straight, and depending on the electrode layout on the membrane, some portions of the reflector may extend distally relative to the proximal-most electrode. If the membrane in its inflated configuration can be divided in half between the distal most location and proximal most location defining a distal portion and proximal portion, the reflector is disposed at least on the proximal portion. In the embodiment shown in
One aspect of the disclosure is an expandable member that includes a diffuse reflector but does not include any ablation element. For example, medical devices that include an inflatable member and at least one camera and at least one light source therein can benefit from a diffuse reflector even if the device is not used for ablation procedures.
While the reflector herein is described as being a diffuse reflector, there may be some uses in which a reflector that reflects light in a specular manner may be beneficial. Alternatively, a reflector can have portions that reflect light in a diffuse manner and portions that reflect light in a specular manner.
As set forth above, light is reflected from the diffuse reflector to provide illumination in the field of the view of the at least one camera. The field of view of the camera can include the view of an electrode secured to the membrane. As set forth herein, the electrodes can be highly reflective, such as if they are comprised of silver. Reflective electrodes causes light incident upon the electrodes to reflect into the camera field of view, which can cause the electrodes to appear as bright spots on the display, possibly interfering with viewing the procedure. It can thus be beneficial to include in the catheter a reflection adjuster that is adapted to reduce specular reflection of light from at least one of the plurality of ablation electrodes into the field of view of an imaging member.
In some embodiments the reflection adjuster is a light absorber. The light absorber can be positioned between the bottom of the electrodes and the membrane. In some embodiments the light absorber is a black adhesive that adheres portions of the electrode to the membrane, as well as acts as a light absorber.
In some embodiments the reflection adjuster is an anti-reflective coating. Exemplary anti-reflective coatings include, for example without limitation, a deposited thin layer of TiO2, MgF2, and “moth eye” structures comprised of nanoparticles approximately 200 nm in diameter spaced 300 nm range, random microstructure secured to or created on the interior surface of the membrane that is adapted to reduce reflection. The anti-reflective coating can be adhered to only a portion of the membrane, such as the portion where the electrodes are disposed. For example, an anti-reflective coating could be applied to only the distal portion of the inner membrane.
A reflection adjuster will reduce the amount of reflection from the bottom of the electrodes, creating a clearer image of the membrane and electrodes from within the membrane.
When the images or video provided by the at least camera are displayed on the display, it can be helpful to be able to visually identify the electrodes on the display. For example, a user interface can be used to control delivery parameters for any of the electrodes, and enabling the physician to easily determine and confirm that a given electrode on the video is a particular electrode on the user interface simplifies the procedures and ensures that the correct electrodes are being activated and used as intended.
In some embodiments the catheter includes an electrode identifier associated with at least one of the plurality of electrodes, and is some embodiments the catheter includes an electrode identifier with each of the plurality of electrodes. The electrode identifier need not be unique to each of the electrode, but in some embodiments it is unique to each electrode. The electrode identifier is visually identifiable and allows an individual to visually associate the identifier with an electrode.
In some embodiments the electrode identifier is an alphanumeric characters disposed on or near each of the electrodes. An example of this type of identifier is described and shown below. For example, an alphanumeric character can be printed on the back of an electrode, or the back of a portion of the flex circuit that is associated with an electrode. An alphanumeric character can also be printed on the membrane near the electrode so that the identifier can be easily associated with a particular electrode.
In some embodiments the electrode identifiers are colors associated with one or more of the electrodes. For example, the electrodes can be color-coded so that a user can visually identify each of the electrodes. In some embodiments a group of electrodes can have a particular color, such as all of the electrodes connected to the same flex circuit are all one color. An additional example of an electrode identifier is the shape of the electrode so that the electrode or group of electrodes can be visually identified based on their shape. For example, groups of electrodes can be circular, oval, hexagonal, rectangular, square, etc. Each electrode could have a unique shape to it as well.
An example of electrode identifiers is described below in the context of overlaying field of view images from a plurality of cameras.
Exemplary materials for the membrane and flex circuit materials can be found in U.S. Pat. No. 8,295,902, issued Oct. 23, 2012; U.S. Pub. No. 2012/0071870, published Mar. 22, 2012. Additional examples of membrane material include PET, Polyurethane, etc. Exemplary materials for the reflector include metalized paints, silicone or urethane resin filled with nonconductive white pigment such as TiO or BaO or BaSo4, preferably non-conductive. Exemplary materials for the electrodes include silver filled silicone or urethane. Exemplary materials for the conductive traces are conductive metals including copper or other such conductive materials. The insulation layers can be known dielectric materials. Exemplary materials for the substrate include Kapton.
As described herein ablation catheters can include ablation and mapping electrodes secured to the exterior of the membrane. In such embodiments the area of tissue mapped is limited to the area of contact defined by the inflatable structure. The rotors being mapped can, however, be larger than the contact area of the inflatable structure, making it more difficult and time consuming to properly map the atrial chamber for rotors. In some embodiments the ablation catheter includes an inflatable membrane, and is also adapted to increase the area that can be mapped to an area that is greater than that defined by the expandable membrane contact surface.
In some of these embodiments mapping arms when appropriately stiff may provide a way to limit the accidental entry of the ablation elements into the pulmonary arteries thereby minimizing the risk of accidental ablation of the artery wall and consequent risk of subsequent stenosis.
In some embodiments a mapping structure on which at least one mapping electrode is disposed is carried outside of the balloon and collapsed between the wall of the delivery catheter and the outside of the ablation catheter. The mapping structure can be secured to the exterior of the ablation catheter. In some embodiments the one or more mapping structures can be deformable splines, the use of which has been described in the cardiac ablation space. For example, the mapping structures can be made of nitinol and are adapted to deform. The mapping structure can thus expand on release from the delivery catheter and can be collapsed to a collapsed delivery configuration when the delivery catheter is advanced distally relative the ablation catheter
In other embodiments a mapping electrode structure is adapted to be delivered through the guide wire lumen of the ablation catheters herein.
Any of the mapping arms that are delivered through the guidewire lumen can alternatively be configured for delivery in the space between the ablation catheter and the delivery catheter, and vice versa.
In yet other embodiments the mapping arms may be woven into a conical braid or braid structure which increases in diameter as it extends distally.
In use, the visualization system allows for real-time visualization of the procedure with a view by one or more cameras disposed within the balloon. The visualization allows for the entire procedure to be visualized, allowing physicians to assess the degree of tissue contact, and see the electrodes, tissue, and lesion formation as it occurs. For clarity,
The description herein of overlaying camera fields of view is related to the disclosure in U.S. Pub. No. 2012/0071870, in particular
In general, for each camera, a mapping function that maps a pixel into a virtual unwrapped display screen, e.g. a dome-shaped screen, surrounding the cameras is computed. The images are then projected back to this virtual display screen using inverse projection, i.e., using cameras as projectors. Data in overlapping regions are combined using compositing including blending or some other means.
Furthermore, the image captured by the camera can have lens barrel aberration.
The mapping function that maps the original pixel coordinates, P(u, v), to a distorted pixel coordinate system due to barrel aberration, {tilde over (P)}(ũ, {tilde over (v)}), can be determined by using the grid target:
The 3D surface of the ellipsoidal balloon can be unwrapped into a 2D plane using the parameterization shown in
A point on the balloon surface can be: (x, y, z). A planar unwrapped image can be constructed from the ellipsoidal balloon geometry by unwrapping the balloon surface as follows:
Where:
θ=g(m) (5)
and g(m) is the well-known “Complete Elliptic Integral of the Second Kind.” The unwrapped 2D surface is defined by the polar coordinates: (m, γ) or in rectilinear coordinates, ({tilde over (x)}, {tilde over (y)}), where:
In summary, the parameters in Table 1 (below) describe the camera geometry of this multi-camera system.
Using the parameters of Table 1, the ({tilde over (x)}, {tilde over (y)}) coordinates of the point on the unwrapped balloon corresponding to each pixel in an image produced by a given camera can be computed. Then the intensity of that pixel can be painted on the unwrapped balloon surface. If more than one camera projects data on to the same location on the unwrapped balloon surface, the data can be combined using any number of exemplary ways, such as blending, maximum value, adaptive blending, alpha blending, weighted averaging, etc. These techniques fall into the general category of “Compositing” as described in Foley et al., “Computer Graphics Principles and Practice”, 1990, Addison Wesley, 2nd Edition. ISBN 0-201-12110-7. In the overlapping areas of images from two or more cameras, the underlying anatomical structure may be slightly misaligned even after following the above steps to grossly align the image due to inaccuracies in the geometric model. In this case, a given tissue structure may appear twice in the overlapping area, similar to double vision. To address this problem, images can be locally warped by using feature tracking. See U.S. Pat. No. 6,659,953, issued Dec. 9, 2003 to Sumanaweera et al., titled “morphing diagnostic ultrasound images for perfusion assessment,” for a description of an exemplary local warping technique.
In
The exemplary method above acquires an image from each of a plurality of cameras, and combines the images to produce a panoramic image. As set forth above, the images from each camera can be deformed using a geometric transformation. The deforming can comprise information associated with the known geometric relationship between the cameras. The deforming procedure can comprise geometric transformations generated using compositing in the overlapping areas of the images. The procedure can comprise the use of weighted averaging. The procedure comprises alpha blending. The deforming procedure can comprise geometric transformations generated using feature tracking in the overlapping areas of the images. The characterization of the geometric relationship between the cameras can comprise the use of experimentally determined optical targets. The geometric relationship can be determined analytically by geometrically modeling the cameras, the fixture containing the cameras and the balloon. The geometric transformation can include geometric transformations that map the balloon onto a planar surface while maintaining the distance between any arbitrary set of points on the 3D surface.
In an exemplary method of use, the catheter is used to ablate cardiac tissue in the treatment of a cardiac arrhythmia. The catheter is advanced into the left atrium using known access procedures including guide wire and guide catheter techniques. Inflation/irrigation fluid is then pumped from a fluid source down inflation/irrigation lumen 52 to inflate the balloon to the configuration shown in
Once it has been determined, depending on the visualization information such as proper placement around a pulmonary vein or mapping electrical information, that the balloon has been properly positioned at the treatment site, an external console, generally shown in
The generator is configured such that electrodes can be used to map tissue, ablate tissue, and stimulate tissue, as desired. Ablation of cardiac tissue to treat aberrant signals is described generally herein and known. The generator is also configured, however, to generate and deliver electrical tissue stimulation signals to the electrodes so that the electrodes stimulate the cardiac tissue. The schematic in
Stimulation of the cardiac tissue can be done for a number of reasons. In an exemplary embodiment stimulation of tissue can be performed during a diagnostics procedure to make sure the electrodes are working. For example, RF energy can be delivered to a first electrode and sensed with another electrode, thereby transferring energy between pairs of electrodes to make sure the pair of electrodes is working. In this exemplary use, the stimulating energy could be delivered before the balloon makes contact with tissue or after it makes contact with tissue, as blood generally has low enough impedance so as not to prevent the diagnostic test. In an alternative embodiment cardiac tissue can be stimulated while tissue is being ablated with other electrodes. For example without limitation, three electrodes could be used to deliver ablation energy to create a lesion between the three electrodes (e.g., a linear ablation), while an electrode on one side of the lesion could be used to deliver stimulating energy to an electrode on another side of the lesion to determine if the tissue is effectively ablated. Exemplary tissue stimulation delivery signal capabilities include currents of 0 to 20 ma, pulse widths of 0 to 100 ms, repetition rates of up to 300 bpm. More preferably 0 to 10 ma, 0 to 10 ms, and up to 180 bpm. Stimulating cardiac tissue in these ways is different than mapping in that mapping measures impedance, while stimulation delivers energy configured to stimulate the cardiac tissue. The disclosure herein therefore includes methods of stimulating cardiac tissue during an ablation procedure, including before the actual ablation, while ablating, or after the ablation has occurred.
One aspect of the disclosure is a method of superimposing an image or images provided by the camera with information or an image that is an indication of at least one of a characteristic of the cardiac tissue and a characteristic of the ablation catheter. The superimposed images (or superimposed information and image) are presented to the physician in a visual display, such as a monitor, and can be part of a remote user interface. The aspect includes methods and systems adapted to superimpose images. The methods and devices herein are also adapted to obtain the information and superimpose the images.
The information that is being superimposed can be any suitable visual indicator of a characteristic of the cardiac tissue or a characteristic of the ablation catheter.
In some embodiments the information that is superimposed onto the image from the cameras is the electrical activity on the cardiac tissue contacting the expandable member.
In some embodiments the information that is superimposed onto the image from the cameras is the localized impedance of the ablation circuit.
In some embodiments the information that is superimposed onto the image from the cameras is the temperature of the cardiac tissue opposed to the balloon.
In some embodiments the camera comprising CMOS cameras are adapted to be responsive to light in the infrared range. The response can be used to estimate the temperature of the tissue before, during and or after ablation. The response can be interpreted by an algorithm and displayed superimposed to the visual light image from the cameras.
In some embodiments an accelerometer is placed at a location in, on or near the ablation balloon. The accelerometer can be used to detect the orientation of the balloon in relation to gravity. The accelerometer can produce acceleration data that is used to determine the accelerometer position in relation to an initial position. The position can be used to construct a database of locations visited by the balloon and/or information collected by the electrodes on the balloon and/or RF power applied to the balloon electrodes. The collection of information can be used to reconstruct a model to provide guidance to the physician in relation to the locations that are treated and locations that need to be treated.
Superimposed information 406 provides a qualitative indication of tissue temperature, in this example, 99 degrees. Information 406 is next to the image of the electrode, whereas information 408 is information that is on the electrode image. Indicator 410 is a red color superimposed on top of the electrode, providing a qualitative indication of “hot.” Information 414 and 416 are superimposed to indicate that the respective electrodes are “on” and “off.”
In some embodiments the superimposed information is all the same type of information. For example, each electrode can, at the same time, be superimposed with information indicating the temperature of tissue. In other embodiments, the type of superimposed information can be different for any of the electrodes.
Additional examples of the type of information that can be superimposed include electrical impedance, which can be visualized quantitatively or qualitatively using any of the indicators herein (e.g., color, numbers). Additionally, mapping signals can be superimposed on the camera images as well.
The outline is that of the final ablation pads 102 (only the large square and the triangle). Apertures 103 are for saline flow. Circuit traces 104 terminate in exposed areas on the ablation pads. Conductive silver paint is used to create the ablation pad geometry and the exposed trace provides conductivity.
Alternately, a black adhesive may be used to darken the areas under silver painted ablation pads 102 to prevent reflections inside the balloon, as is described herein. One method of employing polyimide substrate 101 can eliminate the black adhesive providing a thinner and more compliant mounting surface. In some embodiments there is a light absorbing layer and material disposed between the camera and the electrode, to reduce reflection of the light in the field of view. The light absorber can have the same base material as the electrode, but have no or little conductive properties. In these embodiments at least a portion of the electrode is thus not in direct contact with the expandable member, while the light absorber can be in direct contact with the expandable member. Alternatively, the light absorbing portion may comprise a conductive material such as carbon nanotubes which will provide the light absorbing quality and the electrical conduction quality.
A dielectric area 105 is provided to prevent cross talk and conductivity to the blood or other medium. The proximal side of the flex circuit has two small solder pads 106 where the wires are attached.
An assembled flexible circuit as represented in
Additionally an accelerometer 204 is placed at a location in, on or near the ablation balloon, such accelerometer can be used to detect the orientation of the balloon in relation to gravity and to construct treatment relevant data sets as described herein.
When the physician moves the catheters as described herein, more specifically, when the physician rotates the system around the longitudinal axis of the catheter, the image display will show the internal surface of the balloon fixed and everything outside the balloon (e.g., cardiac tissue) moving. This is due to the fact that the cameras, in the embodiments herein, are fixed in relation to the catheter and balloon system.
Disclosed here therefore is a system to, through image processing, show the internal surface of the balloon rotating while maintaining still, or fixed, the image of everything outside the balloon (e.g., tissue). In this manner, the image of everything that is not part of the catheter will remain fixed, and everything that is part of the catheter will be shown in the video to rotate. In this alternate embodiment, the image that the user views shows the fixed features (e.g., electrodes) being rotated while anatomical features remain still. The anatomical features are the non-fixed features or non-balloon related features in the tissue such as, represented in this view, the pulmonary vein, and the images of burns created by ablation. This is accomplished even though the fixed features move as the camera moves. Keeping the tissue fixed for the user, and having the device components move allows the physician to better control the movement of the device relative to the tissue. To facilitate this procedure the mean rotation of the center of mass of one or more of the key anatomical feature are calculated relative to the location of the fixed features. The mean or other suitable representation of the rotation(s) is then used to rotate the composite image as presented on the user display.
The number and arrangement of the electrodes disposed on the expandable member, each of which is individually addressable and can be used to deliver energy in either monopolar or bipolar mode, provides for a wide variety of lesion formations without having to remove and insert a separate RF catheter. The exemplary methods shown in
One of the advantages of the devices herein is that the number and arrangement of electrodes allow for a wide variety of lesion formations without removing and inserting a new catheter. And the visualization system allows for the entire procedure to be visualized.
One aspect of the disclosure is a delivery catheter comprising concentric sheaths as a steering mechanism with a mapping system built into the distal tip, where a mapping basket resides during delivery in the space between the two concentric shafts and on delivery is pushed forward out into the heart chamber. Examples of deployable mapping baskets are described above. An ablation catheter may then be delivered through the delivery catheter with the mapping basket in place. Target locations for ablation can then be identified using the electrodes on the mapping basket and target locations are then ablated with the ablation catheter. The location of the ablation catheter may in addition be identified and verified by the mapping basket.
One aspect of the disclosure is an ablation catheter that includes an electrode structure that is about 1 cm to about 5 cm in diameter and resides on the end of an inflatable or expandable structure and may comprise any of the following: an ablation catheter with a balloon carrying multiple electrodes. In some embodiments the multiple electrodes are used alternatively as a single ablation electrode then as a set of individual impedance sensing electrodes capable of monitoring the inter electrode impedance. Such measurements are useful in characterizing the efficacy of the burn resulting from the ablation and/or mapping the ablated area before or after the burn. In some embodiments contact pressure sensitive electrodes may be incorporated as a means of verifying appropriate contact of the electrode to the cardiac tissue. In many embodiments irrigation is provided as described elsewhere herein, wherein the irrigation system incorporates a pressure sensor. In such embodiments contact pressure may be inferred from changes in pressure within the irrigation system associated with increasing the outflow resistance at the irrigation outflow ports press against tissue. In other embodiments a balloon within a balloon configuration is used such that irrigation pressure may be isolated from inflation pressure. The change in pressure within the inflation system then is directly correlated to the contact pressure. In another alternative cooling may be provided by recirculation within the balloon as opposed to irrigation.
In some embodiments the contact pressure of an electrode is measured by impedance matching. An alternate means of characterizing the quality of lesions is to measure changes in acoustic impedance in the ultrasonic pass band. The acoustic impedance will be changed from that of normal tissue both as a function of temperature and denaturation. In such an embodiment a forward looking US transponder can be incorporated in the balloon or on the surface of the balloon. Such a sensor may be embodied as an array of one or more transponders, an array of one or more transmitters and an array of one or more receivers, or a single transponder.
In an alternate embodiment temperature of the lesion may be monitored by microwave radiometry.
Contact monitoring may be used to control power delivery. Measurements of electrode contact obtained by any of the means described herein can be used to mediate the amount of power delivered to an electrode. One control algorithm limits power to an electrode such that the power per area of contact surface is maintained at a constant level.
Patient Mapping
This disclosure also includes devices and systems adapted for, and methods of, creating a patient map, such as, for example without limitation, a patient map of at least a portion of a left atrium. Patient map creation combines a plurality of different captured 2D images of the anatomy adjacent the expandable member, each of the plurality of captured 2D images visualizing at least one part of the patient (e.g., tissue) that was in contact with the expandable member when the image was captured. The methods and systems rely on a known or determinable distance between a camera and a location on the expandable member, and a location element in fixed relation with the visualization system, such that the methods can tag each of the plurality of captured 2D images with a position and orientation (together referred to herein as “location) of the 2D image in a global frame of reference. The plurality of 2D image can then be placed in a 3 space (a space defined by 3 coordinates—x, y, z) at their tagged position to create the patient map, which can then be displayed on a monitor or screen. Patient maps as used herein can be represented as projections in 2D or 3D on the screen. For example, a 3D view of the patient map can be displayed, or a 2D representation of the patient map can be displayed on the screen.
The mapping herein includes combining different images captured by the visualization system, wherein the images are captured as the visualization system is moved within and placed in contact with the tissue of the patient (e.g., by moving the catheter or field of view of the camera). As the visualization is moved relative to the patient, a plurality of different 2D images are captured and used to create the maps herein.
The patient maps that are created herein are different from volume patient maps, which can be generated using, for example, ultrasound systems, CT systems, and MRI systems. Volumetric maps are generally created by obtaining 2D slices of a patient using the imaging system, which are then combined into a volume of at least a part of the patient. The systems can allow a user to scan through the 2D slices or the 3D composite to visualize different parts of the volume. The volumes created using these systems are different than the patient maps described herein.
As set forth above, some previous tissue locational mapping systems, such as those that can map a left atrium, use a point-by-point mapping system, and use the relatively large number of individual points to create a 3D patient map. Systems herein can create tissue maps in 3 space without having to rely on this type of point-by-point process.
In some embodiments, the medical device (e.g., cardiac ablation catheter, cardiac visualization and mapping catheter) includes a visualization system, such as any of the systems herein including one or more cameras, and a locational element in a fixed position relative to one or more components of the visualization system. A locational element is generally referred to herein as one or more components whose position and/or orientation can be detected relative to a global frame of reference. For example without limitation, the Aurora electromagnetic tracking system sold by NDI Medical (located in Waterloo, Ontario, Canada N2V 1C5) utilizes a field generator that emits a low-intensity, varying electromagnetic field within which the patient is placed to track the position of a sensor, which can be a plurality of orthogonal coils. The electromagnetic tracking system and software determines the position and orientation of the sensor within the global frame of reference.
In some exemplary embodiments, an ablation catheter having one or more visualization elements (e.g., cameras), such as any of the catheters herein, can also include a locational element in the form of a three orthogonal sensor coils, whose position and orientation can be sensed by a tracking system, such as an electromagnetic tracking system such as the Aurora system sold by NDI, CARTO™, or the EnSite™ NavX™ systems. In some embodiments other magnetic or RF field detectors such as magneto restrictive sensors may replace the coils.
When the locational element has a fixed, or at least known, position and orientation relative to the visualization system, information obtained with the visualization system can then be associated with the tracking system's global frame of reference. For example, in some embodiments, the methods herein determine the location and orientation of a subsurface, or portion, of the target surface, and then compile the subsurfaces into a representation, or patient map, of the target surface.
Some methods are also adapted to image surface structural features (anatomical or created) visualized by the mapping system and map such features onto the patient map of the target surface. Some methods herein are also adapted to characterize one or more anatomical structures in the target tissue and the location in the patient map. Exemplary anatomical structures include the inner surface of a chamber of a heart, such as a left atrium, and exemplary structures include trabeculations, pulmonary veins, corina, vessels just behind the endocardia a septum or other natural features visible via light to which the camera is sensitive. Some methods herein are also adapted to characterize physiological processes occurring within or on the surface of the modeled tissue. Exemplary physiological processes include electrical signals, such as rotors or electrocardiological signals traveling through the cardiac muscle, and are described in more detail below. Some methods herein are also adapted to characterize stimulatable physiological structures occurring within or near the surface of the modeled tissue. Exemplary stimulatable physiological structures include autonomic ganglia, Bachmann's bundle, the phrenic nerve. Some methods herein are also adapted to characterize injuries marking created on and or in the tissue by the medical device such as burns, dye markings, or other injuries.
An exemplary use of the methods and systems herein is in creating a patient map of at least a portion of a chamber of the heart, such as the surface of a left atrium and it's structural and electrical features, such as the pulmonary veins, trabeculations, septum, electrical signals traveling through the muscle including rotors and other aberrant signals, nerves, nerve bundles passing through or near areas of the heart, and any other conduction features. Such an exemplary system can be used in the treatment of atrial fibrillation and other similar diseases.
The following conventions will be used to describe frames of reference, position vectors, and transformations herein. Frames of reference will begin with a capitol letter followed by “f.” Exemplary frames of reference described herein are, the global frame (“Gf”), the locational element frame (“Lf”), and the reference frame of a Camera (“Cf”). Position vectors will be designated herein by pairs of capital letters, the first letter indicative of a starting point, and the second letter indicative of an end point for a position vector. “GL” is an exemplary position vector, describing the position vector starting at the origin in the global frame “Gf” and ending at the locational element. GL is typically measured by the locational tracking system, an example of which is the Aurora system. Vector “LC” describes the position vector measured from the locational element to a camera. LC is typically fixed by the design of the catheter. “CS” is a position vector measured from a point on a camera to a point on a visualized surface. CS is typically calculated as set forth below. “GS” is the position of point “p” on a surface measured from the origin of Gf to the point. When a position vector is listed with a subscript, the subscript indicates the frame in which it is characterized. An element characterized in the global frame may or may not use the frame indication.
A transformation of the coordinates of a position vector in one frame to another is described herein as TSfEf(V), which describes a transformation from “Sf”, the starting frame, to “Ef”, the ending frame, on position vector “V”. When using a system as described above, the position of a point GS(p) on a surface, can be characterized by summing the vector sum GS (which is to be determined)=GL+LC+CS. Given the system described, this vector sum will be described as GS=GL+LCGf+CSGf, given the measurement systems comprised in the system. With appropriate transformations, the equation can be written as: GS=GL+LCGf+CSGf, which can become GL+TLfGf(LC)+TCfGf(CS)), which can become GL+TLfGf(LC)+TLfGf(TCfLf(CS)). Such transformations are described in known literature in additional detail. The final equation can thus be used to determine the position vector GS, which is a characterization of the point in the global frame of reference.
The methods thus far take advantage of contact between a portion of the expandable member and at least a part of the patient (e.g., atrial wall). When the expandable member is in contact with the patient, the distance between the camera and the contacted part of the patient is estimated to be the same as the distance between the camera and the expandable member that is contacting that particular part of the patient. This is because the expandable member is directly adjacent and in contact with the particular part of the patient.
The distance between the camera and the expandable member may be known, or it may be estimated. In some methods the expandable member is filled with inflation fluid (which may be also irrigation fluid flowing through irrigation holes in the expandable member), and the shape of the expandable member stays generally the same when in use. When the shape can be estimated to stay generally the same, the distance between the camera and every location on the expandable member can be determined, assuming that there is a known expansion state or configuration of the expandable member. In some instances, the position of the distal end of the expandable member may be adjustable relative to the proximal end of the expandable member. In these embodiments, the distance between the camera and the expandable member can be determined based on the particular relative position between the distal and proximal ends of the balloon. Thus, when in use and moved into contact with tissue, the distance between the camera and the contacted tissue can always be estimated based on the known distance between the camera and the expandable member. The distance may vary slightly due to very slight changes in configuration, however.
One way in which to maintain the configuration of the expandable member when in use (e.g., when pressing up against atrial wall tissue), is to inflate the expandable membrane to or above a threshold internal fluid pressure, to ensure that the expandable member does not deform meaningful to prevent use of the known distances. For example, without limitation, in some embodiments if the internal fluid pressure is at least about 0.8 psi (e.g., at least about 1.0 psi), the configuration of the expandable member can stay the same, even when urged up against tissue.
In some embodiments herein the distal end of the expandable membrane is secured to distal end of an elongate device that may include a guidewire lumen therein. In some embodiments a hub is disposed at the distal end of the elongate device. The elongate device can be moved axially relative to distal end of the general catheter shaft, which can change the shape of the expandable member. The system can be configured so that some amount of travel in the elongate device (generally as a result of an actuator on the external handle) can be correlated to a change in shape in the expandable member. Alternatively, the system can be adapted such that a position of an external actuator on the handle can indicate the configuration or shape of the expandable member. Thus, the relative axial position of the elongate device can be correlated to a particular configuration of the expandable member. The relative axial position of the elongate device or handle component that controls it can be thus be used to determine the distance between the camera and the location on the expandable member.
The same procedure could be used to create a patient map of a larger portion of the surface of a left atrium.
The patient maps shown in
Creating a patient map requires tagging at least two images for inclusion in the map. The images that will be tagged can be tagged automatically, or can be tagged based on user input. For example, the system can automatically tag all images in which contact has been made and use any of these (or all) of these images to create a map. The system can automatically capture images periodically or non-periodically. Alternatively, the system can be adapted to receive user input (e.g., pushing a button) to cause the tagging of the image to be used in creating the patient map. Any number of automatic or nonautomatic ways can be used to indicate what images should be used in the map creation.
The maps created herein may be displayed in real-time, or the maps can be stored for later visualization and analysis.
In some embodiments the method includes exciting tissue at a particular location using one or more electrodes on the expandable membrane, and then monitoring the response, and based on the response, the method could then map that location. As an example, the device can be positioned against tissue in order to attempt to excite Bachmann's bundle 611 (see
In some embodiments that utilize a locational element, the distance between the camera and the expandable member may not be known, and it may need to be calculated, or estimated. For example, if the expandable member does not maintain a substantially constant shape (e.g., fluid pressure within is not above a threshold), the distance may vary and a way of estimating the distance can enhance the accuracy of the created patient map. One concept utilizes a marker's known dimensions and the visualization system's ability to capture an image of the marker to determine a distance between the camera and a tissue region of interest. When the expandable membrane and associated marker are placed into contact with tissue, the distance between the contacted tissue and the camera is virtually the same as the distance between the marker and the camera. Determining the distance between the camera and marker thus provides the desired distance between the camera and the contacted tissue. The distance between the camera and marker (e.g., an electrode carried by the balloon, flex circuit component, etc.) can be determined by, after contacting tissue, quantifying the visualized dimensions, and comparing them to the known marker dimension relative to the field of view. If the marker's relative dimensions in the captured field of view stay the same, the marker would be at the known distance from the camera, and thus the tissue region would be at the known distance from the camera. If, for example, a particular dimension of the marker in pixels in the captured image were larger than its expected dimension in pixels, the marker (and tissue) or part of it would be closer to the camera than if the balloon were in the predetermined inflation state, likely due to the balloon being distorted inward by collapsing the balloon against the tissue. The dimensions of the marker in the captured image could also, for example, indicate if the marker was skewed due to engagement with a tissue surface that is not coplanar with the image plane. This could be an indicator a curvature in the tissue surface. The marker dimensions in the captured image can thus help determine the distance between the marker and camera, and the distance between the camera and the tissue region.
And once the distance between the camera and contacted tissue is determined, the known relationship between the camera field of view and the global frame of reference (characterized from the camera's fixed position and orientation relative to the locational element) can be used to place the tissue region into the global frame of reference. The process can be repeated for a plurality of tissue regions, and a patient map can then be created by combining the plurality of imaged tissue regions into the global frame of reference, using, for example, known mathematical relations implemented in software.
In embodiments in which the distance is not known and is being estimated, CS is an unknown position vector on the right side of the equation. GL can be sensed by the tracking system, and LC is fixed by the design of the catheter. CS can be estimated (via calculation) using the known dimensions of the marker.
For the case as described above the distance “d” to a scaling element on the surface of a balloon will be approximated by the following relation:
Where xm is a known dimension of a visualization element, pixtot is the total number of pixels across the camera's image plane parallel to the known length feature on the image plane of the camera, pixref is the number of pixels in the camera's image plane which span the known length feature on the image plane of the camera, and a is the angle comprised in the field of view. This applies where the pixels are evenly spaced and the horizontal and vertical pixel counts are equal.
The balloon is in contact with the point of interest, and thus the calculated distance between the camera and the marker can then be used as an estimation of the distance between the camera and the point, or CS. CS can then be used to characterize the position vector GS of the point, in the global frame of reference. This procedure can be repeated for as many points or surface regions as desired to create a patient map.
When combining image frames to create patient maps, some of the reference features (e.g., markers on the device or anatomical references (e.g., pulmonary vein ostia)) may not be scaled precisely due to, for example, differences in distance between the camera and the reference feature when the particular image is captured. For example, the distances between a camera and features can depend on how much contact is made between the expandable membrane and tissue. In some embodiments the patient mapping can thus include automatically scaling one or more reference features in the images to create a patient map in which reference features are to scale, or as close to scale as possible.
Systems herein can be adapted with a plurality of visualization modes. For example, the system can be adapted to generated maps in one or both of 2D planes and 3 spaces. The user interface can allow the user (e.g., physician) to choose between the modes. Alternatively, the user interface can be adapted to display both 2D and 3D models simultaneously.
This disclosure also includes methods of combining (which may also be referred to as stitching) images together to create a composite image. In some embodiments the images can be captured as the visualization system is moved within and relative to the patient. The images can be stitched together by utilizing common features in the images. Any of the landmarks herein can be used as a common feature to combine the images together. For example, natural landmarks such as an ostium that show up in multiple images can be used to stitch a plurality of images together that visualize the ostium. Other landmarks such as created landmarks can be used as a feature common to a plurality of images to combine the images. Electrophysiological landmarks can similarly be used as a common feature to combine images. For example, the method can use timing relationships of monitored signals to help stitch images together. For example, referencing
When combining, or stitching images together, the methods can be used with a locational element and global frame of reference as set above, but the methods need not include the use of a locational element. The use of a locational element may make it easier to create patient maps by having a known sensed position and orientation in a global frame, but it may not be absolutely necessary if landmarks can be used to effectively create a useable map. Thus, the disclosure also includes methods and systems that create maps of combined images that utilize any type of landmark, without the use of a locational element.
In many instances the surface to be mapped will be in motion during the mapping procedure. This is the case for instance when mapping the surface of the left atrium and the heart is beating. In such cases it is useful to capture a signal correlated with the motion, such as in this case an ECG, and temporally correlate the ECG with the data captured during the mapping process with the time at which it was acquired. One way to accomplish this correlation is to tag both sets of data with a timestamp and use the timestamp to accomplish the correlation.
This application claims the benefit of priority of U.S. Provisional Appln. No. 62/185,356, filed Jun. 26, 2015, the disclosure of which is incorporated by reference herein. This application is also a continuation-in-part of U.S. application Ser. No. 14/248,288, filed Apr. 8, 2014, now issued U.S. Pat. No. 9,717,557, which application claims the benefit of priority of the following fourteen U.S. Provisional Applications, the disclosures of which are incorporated by reference herein: Appln. No. 61/809,629, filed Apr. 8, 2013; Appln. No. 61/809,646, filed Apr. 8, 2013; Appln. No. 61/895,880, filed Oct. 25, 2013; Appln. No. 61/809,636, filed Apr. 8, 2013; Appln. No. 61/864,335, filed Aug. 9, 2013; Appln. No. 61/829,985, filed May 31, 2013; Appln. No. 61/820,992, filed May 8, 2013; Appln. No. 61/821,001, filed May 8, 2013; Appln. No. 61/821,014, filed May 8, 2013; Appln. No. 61/934,640, filed Jan. 31, 2014, Appln. No. 61/939,185, filed Feb. 12, 2014; Appln. No. 61/934,647, filed Jan. 31, 2014; Appln. No. 61/945,005, filed Feb. 26, 2014, and Appln. No. 61/947,950, filed Mar. 4, 2014. All of the above-mentioned disclosures are incorporated by reference herein.
Number | Name | Date | Kind |
---|---|---|---|
4448188 | Loeb | May 1984 | A |
4547193 | Rydell | Oct 1985 | A |
4602281 | Nagasaki et al. | Jul 1986 | A |
4611888 | Prenovitz et al. | Sep 1986 | A |
4633879 | Ong | Jan 1987 | A |
4634432 | Kocak | Jan 1987 | A |
4638207 | Radice | Jan 1987 | A |
4646721 | Arakawa | Mar 1987 | A |
4692139 | Stiles | Sep 1987 | A |
4726382 | Boehmer et al. | Feb 1988 | A |
4739766 | Riederer | Apr 1988 | A |
4784133 | Mackin | Nov 1988 | A |
4809680 | Yabe | Mar 1989 | A |
4827907 | Tashiro | May 1989 | A |
4832003 | Yabe | May 1989 | A |
4843275 | Radice | Jun 1989 | A |
4890623 | Cook et al. | Jan 1990 | A |
4961738 | Mackin | Oct 1990 | A |
4968306 | Huss et al. | Nov 1990 | A |
5010895 | Maurer et al. | Apr 1991 | A |
5029574 | Shimamura et al. | Jul 1991 | A |
5041089 | Mueller et al. | Aug 1991 | A |
5069674 | Fearnot et al. | Dec 1991 | A |
5090959 | Samson et al. | Feb 1992 | A |
5109861 | Walinsky et al. | May 1992 | A |
5115472 | Park et al. | May 1992 | A |
5135001 | Sinofsky et al. | Aug 1992 | A |
5180376 | Fischell | Jan 1993 | A |
5187572 | Nakamura et al. | Feb 1993 | A |
5209741 | Spaeth | May 1993 | A |
5213576 | Abiuso et al. | May 1993 | A |
5228442 | Imran | Jul 1993 | A |
5233416 | Inoue | Aug 1993 | A |
5301090 | Hed | Apr 1994 | A |
5306250 | March et al. | Apr 1994 | A |
5309910 | Edwards et al. | May 1994 | A |
5311866 | Kagan et al. | May 1994 | A |
5325847 | Matsuno | Jul 1994 | A |
5343860 | Metzger et al. | Sep 1994 | A |
5377682 | Ueno et al. | Jan 1995 | A |
5385148 | Lesh et al. | Jan 1995 | A |
5391200 | KenKnight et al. | Feb 1995 | A |
5409000 | Imran | Apr 1995 | A |
5411016 | Kume et al. | May 1995 | A |
5430475 | Goto et al. | Jul 1995 | A |
5443470 | Stern et al. | Aug 1995 | A |
5494483 | Adair | Feb 1996 | A |
5505730 | Edwards | Apr 1996 | A |
5515843 | Chang | May 1996 | A |
5515848 | Corbett, III et al. | May 1996 | A |
5524338 | Martyniuk et al. | Jun 1996 | A |
5540679 | Fram et al. | Jul 1996 | A |
5558672 | Edwards et al. | Sep 1996 | A |
5562720 | Stern et al. | Oct 1996 | A |
5569241 | Edwards | Oct 1996 | A |
5571086 | Kaplan et al. | Nov 1996 | A |
5571088 | Lennox et al. | Nov 1996 | A |
5573520 | Schwartz et al. | Nov 1996 | A |
5575772 | Lennox | Nov 1996 | A |
5575788 | Baker et al. | Nov 1996 | A |
5594497 | Ahern et al. | Jan 1997 | A |
5607436 | Pratt et al. | Mar 1997 | A |
5609574 | Kaplan et al. | Mar 1997 | A |
5609606 | O'Boyle | Mar 1997 | A |
5611807 | O'Boyle | Mar 1997 | A |
5626564 | Zhan et al. | May 1997 | A |
5630837 | Crowley | May 1997 | A |
5681308 | Edwards et al. | Oct 1997 | A |
5715825 | Crowley | Feb 1998 | A |
5718701 | Shai et al. | Feb 1998 | A |
5722403 | McGee et al. | Mar 1998 | A |
5735846 | Panescu et al. | Apr 1998 | A |
5769846 | Edwards et al. | Jun 1998 | A |
5769880 | Truckai et al. | Jun 1998 | A |
5779698 | Clayman et al. | Jul 1998 | A |
5795325 | Valley et al. | Aug 1998 | A |
5797837 | Minami | Aug 1998 | A |
5800408 | Strauss et al. | Sep 1998 | A |
5827273 | Edwards | Oct 1998 | A |
5830213 | Panescu et al. | Nov 1998 | A |
5836874 | Swanson et al. | Nov 1998 | A |
5846196 | Siekmeyer et al. | Dec 1998 | A |
5846238 | Jackson et al. | Dec 1998 | A |
5846239 | Swanson et al. | Dec 1998 | A |
5853411 | Whayne et al. | Dec 1998 | A |
5860974 | Abele | Jan 1999 | A |
5871483 | Jackson et al. | Feb 1999 | A |
5879348 | Owens et al. | Mar 1999 | A |
5881727 | Edwards | Mar 1999 | A |
5888577 | Griffin, III et al. | Mar 1999 | A |
5904651 | Swanson et al. | May 1999 | A |
5916213 | Haissaguerre et al. | Jun 1999 | A |
5935075 | Casscells et al. | Aug 1999 | A |
5938660 | Swartz et al. | Aug 1999 | A |
5940126 | Kimura | Aug 1999 | A |
5957950 | Mockros et al. | Sep 1999 | A |
5961513 | Swanson et al. | Oct 1999 | A |
5967986 | Cimochowski et al. | Oct 1999 | A |
5984860 | Shan | Nov 1999 | A |
5991650 | Swanson et al. | Nov 1999 | A |
5997571 | Farr et al. | Dec 1999 | A |
6004269 | Crowley et al. | Dec 1999 | A |
6006119 | Soller et al. | Dec 1999 | A |
6012457 | Lesh | Jan 2000 | A |
6024740 | Lesh et al. | Feb 2000 | A |
6052607 | Edwards et al. | Apr 2000 | A |
6071302 | Sinofsky et al. | Jun 2000 | A |
6102905 | Baxter et al. | Aug 2000 | A |
6117101 | Diederich et al. | Sep 2000 | A |
6123718 | Tu et al. | Sep 2000 | A |
6124883 | Suzuki et al. | Sep 2000 | A |
6134463 | Wittkampf et al. | Oct 2000 | A |
6142993 | Whayne et al. | Nov 2000 | A |
6159203 | Sinofsky | Dec 2000 | A |
6163726 | Wolf | Dec 2000 | A |
6164283 | Lesh | Dec 2000 | A |
6168591 | Sinofsky | Jan 2001 | B1 |
6178346 | Amundson et al. | Jan 2001 | B1 |
6205361 | Kuzma et al. | Mar 2001 | B1 |
6206912 | Goldsteen et al. | Mar 2001 | B1 |
6215231 | Newnham et al. | Apr 2001 | B1 |
6231516 | Keilman et al. | May 2001 | B1 |
6233491 | Kordis et al. | May 2001 | B1 |
6258087 | Edwards et al. | Jul 2001 | B1 |
6270492 | Sinofsky | Aug 2001 | B1 |
6292689 | Wallace et al. | Sep 2001 | B1 |
6315712 | Rovegno | Nov 2001 | B1 |
6375654 | McIntyre | Apr 2002 | B1 |
6384915 | Everett et al. | May 2002 | B1 |
6391024 | Sun et al. | May 2002 | B1 |
6402746 | Whayne et al. | Jun 2002 | B1 |
6416463 | Tsuzuki et al. | Jul 2002 | B1 |
6425877 | Edwards | Jul 2002 | B1 |
6460545 | Kordis | Oct 2002 | B2 |
6485414 | Neuberger | Nov 2002 | B1 |
6500174 | Maguire et al. | Dec 2002 | B1 |
6511478 | Burnside et al. | Jan 2003 | B1 |
6514249 | Maguire et al. | Feb 2003 | B1 |
6517534 | McGovern et al. | Feb 2003 | B1 |
6527769 | Langberg et al. | Mar 2003 | B2 |
6558375 | Sinofsky et al. | May 2003 | B1 |
6558378 | Sherman et al. | May 2003 | B2 |
6572609 | Farr et al. | Jun 2003 | B1 |
6572612 | Stewart et al. | Jun 2003 | B2 |
6579285 | Sinofsky | Jun 2003 | B2 |
6595989 | Schaer | Jul 2003 | B1 |
6599288 | Maguire et al. | Jul 2003 | B2 |
6605055 | Sinofsky et al. | Aug 2003 | B1 |
6605084 | Acker et al. | Aug 2003 | B2 |
6607502 | Maguire et al. | Aug 2003 | B1 |
6635027 | Cragg et al. | Oct 2003 | B1 |
6635054 | Fjield et al. | Oct 2003 | B2 |
6641553 | Chee et al. | Nov 2003 | B1 |
6652515 | Maguire et al. | Nov 2003 | B1 |
6659940 | Adler | Dec 2003 | B2 |
6659953 | Smanaweera et al. | Dec 2003 | B1 |
6660002 | Edwards et al. | Dec 2003 | B1 |
6676656 | Sinofsky | Jan 2004 | B2 |
6692430 | Adler | Feb 2004 | B2 |
6692431 | Kazakevich | Feb 2004 | B2 |
6692455 | Goode et al. | Feb 2004 | B2 |
6692461 | Wantink | Feb 2004 | B2 |
6692462 | Mackenzie et al. | Feb 2004 | B2 |
6692463 | Marteau et al. | Feb 2004 | B1 |
6692464 | Graf | Feb 2004 | B2 |
6692490 | Edwards | Feb 2004 | B1 |
6702782 | Miller et al. | Mar 2004 | B2 |
6736811 | Panescu et al. | May 2004 | B2 |
6743226 | Cosman et al. | Jun 2004 | B2 |
6752805 | Maguire et al. | Jun 2004 | B2 |
6771996 | Bowe et al. | Aug 2004 | B2 |
6780183 | Jimenez, Jr. et al. | Aug 2004 | B2 |
6808524 | Lopath et al. | Oct 2004 | B2 |
6814730 | Li | Nov 2004 | B2 |
6869431 | Maguire et al. | Mar 2005 | B2 |
6872183 | Sampson et al. | Mar 2005 | B2 |
6872206 | Edwards et al. | Mar 2005 | B2 |
6887235 | O'Conner et al. | May 2005 | B2 |
6911027 | Edwards et al. | Jun 2005 | B1 |
6932809 | Sinofsky | Aug 2005 | B2 |
6937899 | Sheldon et al. | Aug 2005 | B2 |
6942657 | Sinofsky et al. | Sep 2005 | B2 |
6949072 | Furnish et al. | Sep 2005 | B2 |
6955173 | Lesh | Oct 2005 | B2 |
6976956 | Takahashi et al. | Dec 2005 | B2 |
6978174 | Gelfand et al. | Dec 2005 | B2 |
7004923 | Deniega et al. | Feb 2006 | B2 |
7030904 | Adair et al. | Apr 2006 | B2 |
7048733 | Hartley et al. | May 2006 | B2 |
7115122 | Swanson et al. | Oct 2006 | B1 |
7137395 | Fried et al. | Nov 2006 | B2 |
7150745 | Stern et al. | Dec 2006 | B2 |
7162303 | Levin et al. | Jan 2007 | B2 |
7166075 | Varghese et al. | Jan 2007 | B2 |
7169140 | Kume | Jan 2007 | B1 |
7207984 | Farr et al. | Apr 2007 | B2 |
7226448 | Bertolero et al. | Jun 2007 | B2 |
7232437 | Berman et al. | Jun 2007 | B2 |
7238179 | Brucker et al. | Jul 2007 | B2 |
7238180 | Mester et al. | Jul 2007 | B2 |
7267674 | Brucker et al. | Sep 2007 | B2 |
7285116 | de la Rama et al. | Oct 2007 | B2 |
7286866 | Okerlund et al. | Oct 2007 | B2 |
7291146 | Steinke et al. | Nov 2007 | B2 |
7293562 | Malecki et al. | Nov 2007 | B2 |
7300397 | Adler et al. | Nov 2007 | B2 |
7310150 | Guillermo et al. | Dec 2007 | B2 |
7320677 | Brouillette | Jan 2008 | B2 |
7344533 | Pearson et al. | Mar 2008 | B2 |
7346381 | Okerlund et al. | Mar 2008 | B2 |
7357796 | Farr et al. | Apr 2008 | B2 |
7365859 | Yun et al. | Apr 2008 | B2 |
7366376 | Shishkov et al. | Apr 2008 | B2 |
7367975 | Malecki et al. | May 2008 | B2 |
7371231 | Rioux et al. | May 2008 | B2 |
7382949 | Bouma et al. | Jun 2008 | B2 |
7396355 | Goldman et al. | Jul 2008 | B2 |
7406970 | Zikorus et al. | Aug 2008 | B2 |
7413568 | Swanson et al. | Aug 2008 | B2 |
7418169 | Tearney et al. | Aug 2008 | B2 |
7427265 | Keilman et al. | Sep 2008 | B1 |
7429260 | Underwood et al. | Sep 2008 | B2 |
7429261 | Kunis et al. | Sep 2008 | B2 |
7445618 | Eggers et al. | Nov 2008 | B2 |
7447408 | Bouma et al. | Nov 2008 | B2 |
7452358 | Stern et al. | Nov 2008 | B2 |
7468062 | Oral et al. | Dec 2008 | B2 |
7473251 | Knowlton et al. | Jan 2009 | B2 |
7481808 | Koyfman et al. | Jan 2009 | B2 |
7481809 | Stern et al. | Jan 2009 | B2 |
7489969 | Knudson et al. | Feb 2009 | B2 |
7507236 | Eggers et al. | Mar 2009 | B2 |
7510555 | Kanzius | Mar 2009 | B2 |
7517346 | Sloan et al. | Apr 2009 | B2 |
7519096 | Bouma et al. | Apr 2009 | B2 |
7529393 | Peszynski et al. | May 2009 | B2 |
7534204 | Starksen et al. | May 2009 | B2 |
7538859 | Tearney et al. | May 2009 | B2 |
7585273 | Adler et al. | Sep 2009 | B2 |
7588535 | Adler et al. | Sep 2009 | B2 |
7617005 | Demarais et al. | Nov 2009 | B2 |
7620451 | Demarais et al. | Nov 2009 | B2 |
7653438 | Deem et al. | Jan 2010 | B2 |
7669309 | Johnson et al. | Mar 2010 | B2 |
7683323 | Kymissis | Mar 2010 | B2 |
7756583 | Demarais et al. | Jul 2010 | B2 |
7758499 | Adler | Jul 2010 | B2 |
7853333 | Demarais | Dec 2010 | B2 |
7879029 | Jimenez | Feb 2011 | B2 |
7928113 | Neamati et al. | Apr 2011 | B2 |
7935108 | Baxter et al. | May 2011 | B2 |
7937143 | Demarais et al. | May 2011 | B2 |
7951144 | Mahajan et al. | May 2011 | B2 |
8007440 | Magnin et al. | Aug 2011 | B2 |
8025661 | Arnold et al. | Sep 2011 | B2 |
8078266 | Saadat et al. | Dec 2011 | B2 |
8167805 | Emery et al. | May 2012 | B2 |
8172747 | Wallace et al. | May 2012 | B2 |
8194121 | Blumzvig et al. | Jun 2012 | B2 |
8295902 | Salahieh et al. | Oct 2012 | B2 |
8323241 | Salahieh et al. | Dec 2012 | B2 |
8333012 | Rothe et al. | Dec 2012 | B2 |
8337492 | Kunis et al. | Dec 2012 | B2 |
8361041 | Fang et al. | Jan 2013 | B2 |
8369921 | Tegg et al. | Feb 2013 | B2 |
8417321 | Saadat et al. | Apr 2013 | B2 |
8419613 | Saadat et al. | Apr 2013 | B2 |
8465421 | Finkman et al. | Jun 2013 | B2 |
8479585 | Shaw-Klein | Jul 2013 | B2 |
8540704 | Melsky et al. | Sep 2013 | B2 |
8560086 | Just et al. | Oct 2013 | B2 |
8617150 | Tsoref et al. | Dec 2013 | B2 |
8702682 | Atanasoska et al. | Apr 2014 | B2 |
8708953 | Salahieh et al. | Apr 2014 | B2 |
8728073 | McDaniel | May 2014 | B2 |
8777857 | Sliwa et al. | Jul 2014 | B2 |
8805466 | Salahieh et al. | Aug 2014 | B2 |
8808281 | Emmons et al. | Aug 2014 | B2 |
8840601 | Salahieh et al. | Sep 2014 | B2 |
8894643 | Watson et al. | Nov 2014 | B2 |
8920369 | Salahieh et al. | Dec 2014 | B2 |
8939970 | Stone et al. | Jan 2015 | B2 |
8968591 | Nishikubo et al. | Mar 2015 | B2 |
8981625 | Nishikubo et al. | Mar 2015 | B2 |
9037259 | Mathur | May 2015 | B2 |
9174050 | Mathur et al. | Nov 2015 | B2 |
9333031 | Salahieh et al. | May 2016 | B2 |
9445862 | Brewster et al. | Sep 2016 | B2 |
9586025 | Salahieh et al. | Mar 2017 | B2 |
9610006 | Salahieh et al. | Apr 2017 | B2 |
9655677 | Salahieh et al. | May 2017 | B2 |
10098694 | Salahieh et al. | Oct 2018 | B2 |
20020002384 | Gilson et al. | Jan 2002 | A1 |
20020068934 | Edwards et al. | Jun 2002 | A1 |
20020087208 | Koblish et al. | Jul 2002 | A1 |
20020095147 | Shadduck | Jul 2002 | A1 |
20020111548 | Swanson et al. | Aug 2002 | A1 |
20020154215 | Schechterman et al. | Oct 2002 | A1 |
20020165535 | Lesh et al. | Nov 2002 | A1 |
20020183623 | Tang et al. | Dec 2002 | A1 |
20030050637 | Maguire et al. | Mar 2003 | A1 |
20030065371 | Satake | Apr 2003 | A1 |
20030097121 | Jolly et al. | May 2003 | A1 |
20030097129 | Davison et al. | May 2003 | A1 |
20030135101 | Webler | Jul 2003 | A1 |
20030233099 | Danaek et al. | Dec 2003 | A1 |
20030236443 | Cespedes et al. | Dec 2003 | A1 |
20040054363 | Vaska et al. | Mar 2004 | A1 |
20040147911 | Sinofsky | Jul 2004 | A1 |
20040147912 | Sinofsky | Jul 2004 | A1 |
20040147913 | Sinofsky | Jul 2004 | A1 |
20040167503 | Sinofsky | Aug 2004 | A1 |
20040243118 | Ayers et al. | Dec 2004 | A1 |
20050004440 | Vanney | Jan 2005 | A1 |
20050065504 | Melsky et al. | Mar 2005 | A1 |
20050171527 | Bhola | Aug 2005 | A1 |
20050203394 | Hauck | Sep 2005 | A1 |
20050203597 | Yamazaki et al. | Sep 2005 | A1 |
20050222558 | Baxter et al. | Oct 2005 | A1 |
20050234436 | Baxter et al. | Oct 2005 | A1 |
20050234437 | Baxter et al. | Oct 2005 | A1 |
20050245892 | Elkins et al. | Nov 2005 | A1 |
20060041277 | Deem et al. | Feb 2006 | A1 |
20060089632 | Barthe et al. | Apr 2006 | A1 |
20060100618 | Chan et al. | May 2006 | A1 |
20060173300 | Oslund et al. | Aug 2006 | A1 |
20060206150 | Demarais et al. | Sep 2006 | A1 |
20060212076 | Demarais et al. | Sep 2006 | A1 |
20060212078 | Demarais et al. | Sep 2006 | A1 |
20060241589 | Heim et al. | Oct 2006 | A1 |
20060247701 | Zacouto | Nov 2006 | A1 |
20060265014 | Demarais et al. | Nov 2006 | A1 |
20060265015 | Demarais et al. | Nov 2006 | A1 |
20060271111 | Demarais et al. | Nov 2006 | A1 |
20060276852 | Demarais et al. | Dec 2006 | A1 |
20070032727 | Omata | Feb 2007 | A1 |
20070073135 | Lee et al. | Mar 2007 | A1 |
20070078507 | Zacouto | Apr 2007 | A1 |
20070112422 | Dehdashtian | May 2007 | A1 |
20070118094 | Bingham et al. | May 2007 | A1 |
20070129720 | Demarais et al. | Jun 2007 | A1 |
20070129760 | Demarais et al. | Jun 2007 | A1 |
20070135875 | Demarais et al. | Jun 2007 | A1 |
20070213616 | Anderson et al. | Sep 2007 | A1 |
20070213671 | Hiatt | Sep 2007 | A1 |
20070219451 | Kula et al. | Sep 2007 | A1 |
20070225634 | Ferren et al. | Sep 2007 | A1 |
20070233185 | Anderson et al. | Oct 2007 | A1 |
20070244501 | Horn et al. | Oct 2007 | A1 |
20070255097 | Jung et al. | Nov 2007 | A1 |
20070270686 | Ritter et al. | Nov 2007 | A1 |
20070287994 | Patel | Dec 2007 | A1 |
20080004652 | Abboud et al. | Jan 2008 | A1 |
20080058590 | Saadat et al. | Mar 2008 | A1 |
20080058591 | Saadat et al. | Mar 2008 | A1 |
20080058836 | Moll et al. | Mar 2008 | A1 |
20080071173 | Aldrich | Mar 2008 | A1 |
20080108867 | Zhou | May 2008 | A1 |
20080125772 | Stone et al. | May 2008 | A1 |
20080188912 | Stone et al. | Aug 2008 | A1 |
20080205481 | Faries, Jr. et al. | Aug 2008 | A1 |
20080262489 | Steinke | Oct 2008 | A1 |
20080275300 | Rothe et al. | Nov 2008 | A1 |
20080275445 | Kelly et al. | Nov 2008 | A1 |
20080281293 | Peh et al. | Nov 2008 | A1 |
20080281312 | Werneth et al. | Nov 2008 | A1 |
20080281322 | Sherman et al. | Nov 2008 | A1 |
20080296152 | Voss | Dec 2008 | A1 |
20090024195 | Rezai et al. | Jan 2009 | A1 |
20090030276 | Saadat et al. | Jan 2009 | A1 |
20090030412 | Willis et al. | Jan 2009 | A1 |
20090046171 | Kogan et al. | Feb 2009 | A1 |
20090051763 | Adler et al. | Feb 2009 | A1 |
20090054786 | Beckermus | Feb 2009 | A1 |
20090054787 | Adler et al. | Feb 2009 | A1 |
20090054803 | Saadat et al. | Feb 2009 | A1 |
20090076498 | Saadat et al. | Mar 2009 | A1 |
20090125022 | Saadat et al. | May 2009 | A1 |
20090137893 | Seibel et al. | May 2009 | A1 |
20090203962 | Miller et al. | Aug 2009 | A1 |
20090227885 | Lowery et al. | Sep 2009 | A1 |
20090227999 | Willis et al. | Sep 2009 | A1 |
20090240249 | Chan et al. | Sep 2009 | A1 |
20090247933 | Maor et al. | Oct 2009 | A1 |
20090254142 | Edwards et al. | Oct 2009 | A1 |
20090275799 | Saadat et al. | Nov 2009 | A1 |
20090299354 | Melsky et al. | Dec 2009 | A1 |
20090312754 | Lenihan et al. | Dec 2009 | A1 |
20090318757 | Singh | Dec 2009 | A1 |
20090318759 | Jacobsen et al. | Dec 2009 | A1 |
20090326320 | Sinofsky et al. | Dec 2009 | A1 |
20090326321 | Jacobsen et al. | Dec 2009 | A1 |
20090326572 | Peh et al. | Dec 2009 | A1 |
20100016957 | Jager et al. | Jan 2010 | A1 |
20100087782 | Ghaffari et al. | Apr 2010 | A1 |
20100121142 | Ouyang et al. | May 2010 | A1 |
20100204560 | Salahieh et al. | Aug 2010 | A1 |
20100204561 | Saadat et al. | Aug 2010 | A1 |
20100238279 | Thoms et al. | Sep 2010 | A1 |
20110034790 | Mourlas et al. | Feb 2011 | A1 |
20110034912 | de Graff et al. | Feb 2011 | A1 |
20110040172 | Carpentier et al. | Feb 2011 | A1 |
20110046600 | Crank | Feb 2011 | A1 |
20110077579 | Harrison et al. | Mar 2011 | A1 |
20110082449 | Melsky et al. | Apr 2011 | A1 |
20110082450 | Melsky et al. | Apr 2011 | A1 |
20110082451 | Melsky | Apr 2011 | A1 |
20110082452 | Melsky et al. | Apr 2011 | A1 |
20110152352 | Hata et al. | Jun 2011 | A1 |
20110160514 | Long et al. | Jun 2011 | A1 |
20110160584 | Paul et al. | Jun 2011 | A1 |
20110201973 | Stephens et al. | Aug 2011 | A1 |
20110237940 | Raleigh | Sep 2011 | A1 |
20110257523 | Hastings et al. | Oct 2011 | A1 |
20110292258 | Adler et al. | Dec 2011 | A1 |
20110301418 | Gharib et al. | Dec 2011 | A1 |
20110319752 | Steinberg et al. | Dec 2011 | A1 |
20120004529 | Tolkowsky et al. | Jan 2012 | A1 |
20120004537 | Tolkowsky et al. | Jan 2012 | A1 |
20120069367 | Iguchi | Mar 2012 | A1 |
20120071870 | Salahieh et al. | Mar 2012 | A1 |
20120116438 | Salahieh et al. | May 2012 | A1 |
20120130171 | Barak et al. | May 2012 | A1 |
20120165669 | Barley et al. | Jun 2012 | A1 |
20120302877 | Harks et al. | Nov 2012 | A1 |
20130079645 | Amirana et al. | Mar 2013 | A1 |
20130085493 | Bloom et al. | Apr 2013 | A1 |
20130137920 | Schaeffer et al. | May 2013 | A1 |
20130138082 | Salahieh et al. | May 2013 | A1 |
20130172726 | Saadat et al. | Jul 2013 | A9 |
20130172883 | Lopes et al. | Jul 2013 | A1 |
20130178850 | Lopes et al. | Jul 2013 | A1 |
20130178851 | Lopes et al. | Jul 2013 | A1 |
20130204125 | Chang et al. | Aug 2013 | A1 |
20130204126 | Namati et al. | Aug 2013 | A1 |
20130231533 | Papademetriou et al. | Sep 2013 | A1 |
20130289350 | Lerner et al. | Oct 2013 | A1 |
20130289358 | Melsky et al. | Oct 2013 | A1 |
20130304065 | Lopes et al. | Nov 2013 | A1 |
20130317497 | Edwards et al. | Nov 2013 | A1 |
20140031810 | Mahvi et al. | Jan 2014 | A1 |
20140058197 | Salahieh et al. | Feb 2014 | A1 |
20140107623 | Salahieh et al. | Apr 2014 | A1 |
20140121470 | Scharf et al. | May 2014 | A1 |
20140171942 | Werneth et al. | Jun 2014 | A1 |
20140180273 | Nair | Jun 2014 | A1 |
20140213850 | Levy et al. | Jul 2014 | A1 |
20140243680 | Raleigh | Aug 2014 | A1 |
20140296643 | Levy et al. | Oct 2014 | A1 |
20140296866 | Salman et al. | Oct 2014 | A1 |
20140309495 | Kirma et al. | Oct 2014 | A1 |
20140316198 | Krivopisk et al. | Oct 2014 | A1 |
20140320617 | Parks et al. | Oct 2014 | A1 |
20140333743 | Gilreath et al. | Nov 2014 | A1 |
20140357956 | Salahieh et al. | Dec 2014 | A1 |
20140358140 | Emmons et al. | Dec 2014 | A1 |
20140364691 | Krivopisk et al. | Dec 2014 | A1 |
20140364692 | Salman et al. | Dec 2014 | A1 |
20140364694 | Avron et al. | Dec 2014 | A1 |
20140370072 | Hossainy et al. | Dec 2014 | A1 |
20150073341 | Salahieh et al. | Mar 2015 | A1 |
20150094656 | Salahieh et al. | Apr 2015 | A1 |
20150327753 | Amirana et al. | Nov 2015 | A1 |
20150351836 | Prutchi | Dec 2015 | A1 |
20160051321 | Salahieh et al. | Feb 2016 | A1 |
20160157954 | Sagon et al. | Jun 2016 | A1 |
20170027601 | Salahieh et al. | Feb 2017 | A1 |
20170042614 | Salahieh et al. | Feb 2017 | A1 |
20170042615 | Salahieh et al. | Feb 2017 | A1 |
20170080184 | Salahieh et al. | Mar 2017 | A1 |
20170173303 | Salahieh et al. | Jun 2017 | A1 |
Number | Date | Country |
---|---|---|
1085416 | Apr 1994 | CN |
1781161 | May 2006 | CN |
101505672 | Aug 2009 | CN |
101511292 | Aug 2009 | CN |
101888813 | Nov 2010 | CN |
101956919 | Jan 2011 | CN |
203271765 | Sep 2013 | CN |
4104092 | Aug 1991 | DE |
0322852 | Jul 1989 | EP |
0802768 | Oct 1997 | EP |
0637943 | Apr 1998 | EP |
623360 | Mar 1999 | EP |
0723467 | Apr 2002 | EP |
0693955 | Jan 2003 | EP |
1382366 | Jan 2004 | EP |
1463441 | Oct 2004 | EP |
1604613 | Dec 2005 | EP |
1991301 | Nov 2008 | EP |
2335757 | Jun 2011 | EP |
H08-504333 | May 1996 | JP |
2000-504242 | Apr 2000 | JP |
2003510126 | Mar 2003 | JP |
2004237077 | Aug 2004 | JP |
2008142346 | Jun 2006 | JP |
2007516010 | Jun 2007 | JP |
2009507617 | Feb 2009 | JP |
2009539575 | Nov 2009 | JP |
2010507403 | Mar 2010 | JP |
2010507404 | Mar 2010 | JP |
2012525898 | Oct 2012 | JP |
WO8705748 | Sep 1987 | WO |
WO9505775 | Mar 1995 | WO |
WO9510319 | Apr 1995 | WO |
WO9831271 | Jul 1998 | WO |
WO 9900060 | Jan 1999 | WO |
WO9902096 | Jan 1999 | WO |
WO9926530 | Jun 1999 | WO |
WO9942176 | Aug 1999 | WO |
WO9944519 | Sep 1999 | WO |
WO9945855 | Sep 1999 | WO |
WO0038580 | Jul 2000 | WO |
WO0056237 | Sep 2000 | WO |
WO 0066014 | Nov 2000 | WO |
WO0067648 | Nov 2000 | WO |
WO0067656 | Nov 2000 | WO |
WO0108575 | Feb 2001 | WO |
WO0108576 | Feb 2001 | WO |
WO0113812 | Mar 2001 | WO |
WO0168178 | Sep 2001 | WO |
WO0172373 | Oct 2001 | WO |
WO0187169 | Nov 2001 | WO |
WO0187174 | Nov 2001 | WO |
WO0195820 | Dec 2001 | WO |
WO0240089 | May 2002 | WO |
WO03013624 | Feb 2003 | WO |
WO0532370 | Apr 2005 | WO |
WO2005065563 | Jul 2005 | WO |
WO2006077573 | Jul 2006 | WO |
WO2007001981 | Jan 2007 | WO |
WO2007047993 | Apr 2007 | WO |
WO2007059195 | May 2007 | WO |
WO2008061152 | May 2008 | WO |
WO 2009067695 | May 2009 | WO |
WO 2009088678 | Jul 2009 | WO |
WO 2009132137 | Oct 2009 | WO |
WO2009151600 | Dec 2009 | WO |
WO 2009155441 | Dec 2009 | WO |
2011143468 | Nov 2011 | WO |
WO2011153434 | Dec 2011 | WO |
WO2012033837 | Mar 2012 | WO |
WO 2013049601 | Apr 2013 | WO |
WO2013098732 | Jul 2013 | WO |
2014036439 | Mar 2014 | WO |
WO2014100259 | Jun 2014 | WO |
WO2014168987 | Oct 2014 | WO |
Entry |
---|
Extended European Search Report issued in EP App;lication 15811644.2, dated Dec. 12, 2017, 8 pages. |
International Preliminary Report on Patentability issued in PCT/US2016/039646; dated Jan. 4, 2018, 6 pages. |
International Preliminary Report on Patentability issued in PCT/US2016/062323, dated May 31, 2018, 10 pages. |
International Search Report and Written Opinion issued in PCT/US2016/062323, dated Apr. 5, 2017, 15 pages. |
Tymecki, Lukasz, et al. “Strip Thick-Film Silver Ion-Selective Electrodes.” Sensors and Actuators B 96 (2003), pp. 482-488. |
Salahieh et al.; U.S. Appl. No. 15/339,724 entitled “Ablation catheters,” filed Oct. 31, 2016. |
Salahieh et al.; U.S. Appl. No. 15/339,745 entitled “Ablation catheters,” filed Oct. 31, 2016. |
Denham et al.; Ultrasonic resonant modes of piezoelectric balloons under internal pressure; J. Acoust. Soc. Am.; 132(3); pp. 1368-1377; Sep. 2012. |
Foley et al.; Computer Graphics Principles and Practice; 2nd Edition; Addison Wesley (publisher); pp. 835-843; Jun. 1990. |
Gibson; Visualization of lesion transmurality and depth of necrosis using an ablation catheter that incorporates ultrasound imaging: a small step or a major leap forward on the road to a more durable catheter ablation procedure for treatment of atrial fibrillation; Heart Rhythm; 8(2); pp. 313-314; Feb. 2011. |
Hu et al.; In-vivo pan/tilt endoscope with integrated light source; Intelligent Robots and Systems; IROS 2007. IEEE/RSJ International Conference on; pp. 1284-1289; San Diego, CA, USA: Oct. 29-Nov. 2, 2007. |
Tymecki et al; Strip thick-film silver ion-selective electrodes; Sensors and Actuators B; 96(3); pp. 482-488; Dec. 1, 2003. |
Wippermann et al.; Low cost video endoscopes with simplified integration; In SPIE Photonics Europe; International Society for Optics and Phtonics; vol. 7716; pp. 77160M-1-77160M-9; Apr. 30, 2010. |
Wright et al.; Real-time lesion assessment using a novel combined ultrasound and radiofrequency ablation catheter; Heart Rhythm; 8(2); pp. 304-312; Feb. 2011. |
Wu et al.; Transmural ultrasound imaging of thermal lesion and action potential changes in perfused canine cardiac wedge preparations by high intensity focused ultrasound ablation; Plos One; 8(12); pp. 1-13; Dec. 2013. |
Salahieh et al.; U.S. Appl. No. 13/830,624 entitled “Local Sympathectomy for PVD,” filed Mar. 14, 2013. |
Salahieh et al.; U.S. Appl. No. 61/622,495 entitled “Energy Delivery Device with Rapid Exchange Features,” filed Apr. 10, 2012. |
Salahieh et al.; U.S. Appl. No. 61/624,206 entitled “Energy delivery device and methods of use,” filed Apr. 13, 2012. |
Salahieh et al.; U.S. Appl. No. 15/082,923 entitled “Steerable medical devices, systems, and methods of use,” filed Mar. 28, 2016. |
Salahieh et al.; U.S. Appl. No. 15/092,442 entitled “Intravascular tissue disruption,” filed Apr. 6, 2016. |
Salahieh et al.; U.S. Appl. No. 15/138,050 entitled “Steerable medical devices, systems, and methods of use,” filed Apr. 25, 2016. |
Salahieh et al.; U.S. Appl. No. 15/167,509 entitled “Intravascular tissue disruption,” filed May 27, 2016. |
Extended European Search Report issued in EP Application 14782484.1, dated Oct. 31, 2016, 9 pages. |
International Preliminary Report on Patentability issued in PCT/US2014/033393, dated Oct. 13, 2015, 11 pages. |
International Search Report issued in PCT/US2014033393, dated Aug. 19, 2014, 5 pages. |
Salahieh et al.; U.S. Appl. No. 15/375,027 entitled “Steerable medical devices, systems, and methods of use,” filed Dec. 9, 2016. |
Salahieh et al.; U.S. Appl. No. 15/452,413 entitled “Steerable delivery sheaths,” filed Mar. 7, 2017. |
Salahieh et al.; U.S. Appl. No. 15/640,306 entitled “Ablation catheters,” filed Jun. 30, 2017. |
Number | Date | Country | |
---|---|---|---|
20170143201 A1 | May 2017 | US |
Number | Date | Country | |
---|---|---|---|
62185356 | Jun 2015 | US | |
61947950 | Mar 2014 | US | |
61945005 | Feb 2014 | US | |
61939185 | Feb 2014 | US | |
61934640 | Jan 2014 | US | |
61934647 | Jan 2014 | US | |
61895880 | Oct 2013 | US | |
61864335 | Aug 2013 | US | |
61829985 | May 2013 | US | |
61821014 | May 2013 | US | |
61821001 | May 2013 | US | |
61820992 | May 2013 | US | |
61809629 | Apr 2013 | US | |
61809646 | Apr 2013 | US | |
61809636 | Apr 2013 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 14248288 | Apr 2014 | US |
Child | 15194444 | US |